Förpackning om 10 vialer7 i lagerSpara 20 %Selank 30 mg
Anxiolytisk forskningspeptid
Buy Selank in Australia for anxiolytic research. Lab-verified, lyophilised, Australian-shipped.
Enbart för forskningsbruk. Denna förening säljs strikt för in vitro-forskning och laboratorieändamål och är inte avsedd för mänsklig konsumtion eller terapeutisk användning. Genom att köpa bekräftar du att du är en kvalificerad forskare och godkänner vår fullständiga ansvarsfriskrivning.
Endast 7 förpackningar kvar
Syntetisk heptapeptidanalog av tuftsin studerad för anxiolytiska och kognitiva forskningsapplikationer.
Selank is a synthetic heptapeptide derived from tuftsin (TKPR) — a peptide fragment of the immunoglobulin G heavy chain. It was developed alongside Semax in Russian peptide research and is one of the most extensively studied anxiolytic research peptides in Eastern European literature. Quantum Labs supplies Selank as a lyophilised powder for Australian research applications.
Research on Selank covers models of anxiety, learning and memory, and neuroimmune signalling. Like Semax, intranasal delivery is the primary research route. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanism
Forskning tyder på interaktion med GABAerga vägar och cytokinmodulering hos studiedeltagare.
HPLC-verifierad mot en renhetsspecifikation på ≥99 %. Oberoende testad av ackrediterade tredjepartslaboratorier.
Selank — vanliga frågor
What is Selank?
Selank is a synthetic heptapeptide derived from tuftsin, an immunoglobulin G fragment. It is studied in anxiolytic and nootropic research with published work in Russian and Eastern European literature.
Is Selank legal in Australia?
Selank is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Selank for research use only.
What is the difference between Selank and Semax?
Semax is a fragment of ACTH (adrenocorticotropic hormone) studied for nootropic and neuroprotective effects. Selank is a fragment of tuftsin studied for anxiolytic effects. They originated in the same Russian peptide-research lineage and use the same intranasal delivery route but target different receptor systems.
How is Selank administered in research?
Selank is delivered intranasally in most research protocols. The peptide is well-absorbed across the nasal mucosa and reaches the central nervous system through olfactory-pathway transport.
What is the typical Selank research dosage?
Published Russian research has used intranasal Selank doses in wide ranges depending on the model. Human therapeutic dosing in Australia is not established. Researchers should consult primary literature for protocol-specific guidance.
Can Selank and Semax be used in the same research protocol?
Combined Selank + Semax research protocols are common because the two compounds target complementary pathways — Selank predominantly anxiolytic, Semax predominantly nootropic — and share the same intranasal delivery route.
Guider relaterade till Selank
Forskare utforskar också
Förpackning om 10 vialerSpara 22 %DSIP
Lyofiliserat pulver5 mg · 2 strengths
Delta sleep-inducing peptide
Förpackning om 10 vialerSpara 20 %Semax
Näspray30 mg · 3 strengths
Nootrop forskningsheptapeptid
I 1 stack
UtvaldFörpackning om 10 vialerSpara 25 %NAD+
Lyofiliserat pulver100 mg · 3 strengths
Cellulär redoxkofaktor
I 1 stack